Adipose tissue: FSH antibody prevents obesity and loss of bone (Nature Clinical Practice Endocrinology & Metabolism)

Levels of follicle-stimulating hormone (FSH) rise during the peri-menopausal transition; women often gain visceral fat and experience bone loss at this time, which puts them at increased risk of fractures, type 2 diabetes mellitus and cardiovascular disease. Current treatment strategies do not adequately address these